Hap Trading, LLC Atossa Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$0.5 - $1.01 $20,100 - $40,602	-40,200 Reduced 33.36%	80,300 $0
Q3 2022 Nov 14, 2022	SELL	$0.82 - $1.14 $656 - $911	-800 Reduced 0.66%	120,500 $4,000
Q2 2022 Aug 12, 2022	BUY	$0.85 - $1.28 $14,705 - $22,144	17,300 Added 16.63%	121,300 $16,000
Q1 2022 May 12, 2022	SELL	$1.11 - $1.74 $12,099 - $18,966	-10,900 Reduced 9.49%	104,000 $19,000
Q4 2021 Feb 14, 2022	BUY	$1.6 - $3.27 $31,200 - $63,765	19,500 Added 20.44%	114,900 $23,000
Q3 2021 Nov 10, 2021	SELL	$2.89 - $6.4 $112,710 - $249,600	-39,000 Reduced 29.02%	95,400 $41,000
Q2 2021 Aug 11, 2021	BUY	$1.52 - $8.62 $20,216 - $114,645	13,300 Added 10.98%	134,400 $294,000
Q1 2021 May 14, 2021	BUY	$0.92 - $4.33 $111,412 - $524,363	121,100 New	121,100 $26,000

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $130M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.